Building on Canada's Strengths in Regenerative Medicine
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
2011/2012 Annual Report
BUILDINGALEGACY Stem Cell Network 2011-2012 Annual Report StemCell Network 2011-2012 Annual Report TABLE OF CONTENTS Directors’ Message .........................................................................................2 Bridging The Translational Gap ...................................................................4 In Profile: Dr. Denis-Claude Roy .............................................7 The High-Throughput Revolution................................................................8 In Profile: Dr. Aaron Schimmer .........................................11 See The Potential: An Industry-Academia Hybrid ...............................12 In Profile: Dr. Corinne Hoesli ..............................................14 A Research Conference Built by the Community .................................15 In Profile: Dr. Peter Zandstra .............................................17 Building an Informed Public.......................................................................18 In Profile: Angela McDonald .............................................21 Network Community ...................................................................................22 2011-12 Financial Statements ...................................................................25 Directors’ Message Message from SCN’s Board Chair, Scientific Director, and Executive Director t’s year 12. On paper, the Stem Cell Network has entered its for blood cancers at the University of Montréal. Dr. Roy’s project, sunset years, but we’re not ready to rest on our laurels -
STEMCELLNETWORK.CA the Mission of the Stem Cell
STEM CELL NETWORK SUMMER 2006 VOLUME 5, NUMBER 1 FATHERS OF THE FIELD How two quiet Canadians changed the course of history in biological research. CRITICAL MASS AHEAD OF THE CURVE A CANADIAN A pioneering past and a culture of Finding the way inside the ‘black box’ COMES HOME collaboration combine to make Toronto of cancer, Dr. John Dick has changed One of America’s leading researchers a world leader in stem cell science. our understanding of how to fight takes up a new challenge in the city the deadly disease. where he began his brilliant career. WWW.STEMCELLNETWORK.CA The mission of the Stem Cell Network is to be a catalyst for realizing the full potential of stem cell research for Canadians. STEM CELL NETWORK Frank Gleeson, Chair, Board of Directors Dr. Michael Rudnicki, Scientific Director Dr. Janet Rossant, Deputy Scientific Director Drew Lyall, Executive Director Cathy Campbell, SCN Communications Lori Barron, SCN Communications Joe Sornberger, Writer CONTACT US AT: 451 Smyth Road, Ottawa, ON K1H 8M5 Tel: (613)562.5696 Fax: (613)562.5631 Website: www.stemcellnetwork.ca Publication Mail Agreement Number 40664504 The contents of this publication may be reprinted or used in radio or television without permission. However, a credit is requested. In print, please send a copy to the Stem Cell Network. STEM CELL NETWORK TABLE OF CONTENTS Welcome to Toronto - Dr. Michael Rudnicki .......................................1 Critical Mass .................................................................................2 The Fathers of the Field .................................................................8 A Canadian comes home - Interview with Dr. Gordon Keller ...............14 The world’s best feel right at home ..............................................15 On the Cover: Ahead of the curve - Interview with Dr. -
2010 Annual Report 2010 Annual Report 60Th Anniversary Special Edition
UBC Department of Medicine UBC Department Department of Medicine 2010 Annual Report 2010 Annual Report 60th Anniversary Special Edition University of British Columbia, Vancouver, Canada C O N T E N T S Message from the President and Vice-Chancellor 3 Message from the Dean, Faculty of Medicine 4 Message from the Chair, Department of Medicine 5 Heads & Directors 8 Departmental Strategic Directions 2010 9 2009 Progress Statements 13 Leadership History of the UBC Department of Medicine 17 A Historical Journey - celebrating 60 years 22 Administration 76 Research 79 Committees 80 Division Reports AIDS 84 University of British Columbia Allergy & Immunology 94 Department of Medicine Cardiology 97 2010 Annual Report Critical Care Medicine 112 Endocrinology 118 Gastroenterology 121 Graydon S. Meneilly General Internal Medicine & Community Internal Medicine 126 Professor and Eric W. Hamber Chair Geriatric Medicine 134 Head, UBC Department of Medicine Hematology 137 Head, Department of Medicine, Infectious Diseases 140 Vancouver Hospital Medical Oncology 142 Nephrology 144 Contributors Neurology 150 Division Heads and Administrators Physical Medicine & Rehabilitation 164 Program Directors and Managers Respiratory Medicine 167 Staff & Faculty Rheumatology 170 Linda Rasmussen Members at Large 176 Director of Administration Department of Medicine Education Programs Clinical Investigator Program 177 Experimental Medicine Graduate Program 178 Editor Postgraduate Education Program 183 Donna Combs UBC Internal Medicine Advocacy 185 Department of Medicine International Health Project 187 Undergraduate Education Program 189 Designer Discipline Site Specific Leaders (DSSL) 191 Sabina Fitzsimmons Anthony Lam Canada Research Chairs, Endowed Chairs & Professorships 196 Department of Medicine Research Funding 207 Publications 207 Cover photo Affiliated Institutes 208 Photospin Mentoring Program 209 Honours & Awards 210 Staff & Divison Head Photography 2010 Vancouver Winter Olympics 211 Janis Franklin Facts and Figures 219 Andy Fang Photos St. -
CURRICULUM VITAE Marco Antonio Marra
January 21, 2020 CURRICULUM VITAE Marco Antonio Marra Canada’s Michael Smith Genome Sciences Centre, Telephone: (604)-675-8162 (Office) BC Cancer (604)-675-8168 (Assistant) 675 West 10th Avenue, Vancouver, Fax: (604)-675-8178 British Columbia V5Z 1L3 CANADA. E-mail: [email protected] Department of Medical Genetics , Citizenship: Canada University of British Columbia. AREAS OF EXPERTISE: genomics, bioinformatics, genetics, epigenomics, cancer biology EDUCATION: Start Date End Date Institution Degree Supervisor 09/1989 09/1994 Simon Fraser University PhD (Genetics) Dr. David Baillie 09/1984 05/1989 Simon Fraser University BSc (Molecular & Cell Biology) PhD Thesis Title: Genome analysis in Caenorhabditis elegans: Genetic and molecular identification of genes tightly linked to unc-22(IV). ACADEMIC EMPLOYMENT HISTORY: 01/2015 Present Head, Department of Medical Genetics, Faculty of Medicine, University of British Columbia 04/2009 Present Distinguished Scientist, BC Cancer Research Centre, BC Cancer 07/2007 Present Professor, Department of Medical Genetics, University of British Columbia 04/2002 Present Director, Genome Sciences Centre, BC Cancer 01/2001 Present Adjunct Professor, Department of Molecular Biology and Biochemistry, Simon Fraser University 06/2000 Present Associate Member, Michael Smith Laboratories, University of British Columbia 01/2011 06/2018 Co-Founder & Co-Director, Genome Science and Technology Graduate Program, University of British Columbia 07/2002 06/2007 Associate Professor, Department of Medical Genetics, University of British Columbia 10/2000 04/2002 Co-Director (Scientific), Genome Sequence Centre, BC Cancer Agency 02/2000 06/2002 Adjunct Professor, Department of Medical Genetics, University of British Columbia 10/1999 03/2009 Senior Scientist, BC Cancer Research Centre, BC Cancer Agency 10/1999 09/2000 Associate Director, Genome Sequence Centre, BC Cancer Agency 10/1999 09/2000 Head, Mapping and Sequencing, Genome Sequence Centre, BC Cancer Agency 09/1998 09/1999 Research Faculty Instructor, Washington University School of Medicine (St. -
GOING FURTHER – TOGETHER Strategic Plan 2015-2020
GOING FURTHER – TOGETHER Strategic Plan 2015-2020 October 22nd, 2015 Table of contents ACKNOWLEDGMENTS ..................................................................................................................... 4 FOREWORD ...................................................................................................................................... 5 1 CONTEXT – WHAT IS CELLCAN ................................................................................................. 6 1.1 Description ...................................................................................................................... 6 1.2 Vision ............................................................................................................................... 6 1.3 Current mission ............................................................................................................... 6 1.4 Founding CellCAN Network Affiliates .............................................................................. 6 1.5 Governance and management ........................................................................................ 6 2 STRATEGIC ANALYSIS ............................................................................................................... 8 2.1 Key concepts .................................................................................................................... 8 2.2 General Environmental Analysis ...................................................................................... 8 2.2.1 Canadian -
Canadian Asset Map for Stem Cell
CANADIAN ASSET MAP FOR STEM CELL AND REGENERATIVE MEDICINE This publication is also available online in HTML and .pdf formats at www.ic.gc.ca/stemcells This publication is available upon request in accessible formats. Contact: Multimedia Services Section Communications and Marketing Branch Industry Canada Room 441E, East Tower 235 Queen Street Ottawa ON K1A 0H5 Telephone: 613-995-8552 Fax: 613-954-6436 Email: [email protected] Aussi offert en français sous le titre : Carte des ressources canadiennes dans les domaines des cellules souches et de la médecine régénérative Cette publication est disponible en ligne en formats HTML et pdf à www.ic.gc.ca/cellulessouches Release Note: Published by Industry Canada, March 2012. To obtain an electronic copy of this report, please visit www.ic.gc.ca/stemcells PERMISSION TO REPRODUCE: Non-commercial Reproduction Except as otherwise specifically noted, the information in this publication may be reproduced, in part or in whole and by any means, without change or further permission for non-commercial re-distribution, provided that due diligence is exercised in ensuring the accuracy of the information reproduced; that International BioPharma Solutions Ltd. is identified as the source; and that the reproduction is not represented as an official version of the information reproduced, nor as having been made in affiliation with, or with the endorsement of Industry Canada or International BioPharma Solutions Ltd. Commercial Reproduction Reproduction of materials in this document, in whole or in part, for the purposes of commercial redistribution is prohibited except with written permission from International BioPharma Solutions Ltd. For permission to reproduce the information in this publication for commercial redistribution, please contact : International BioPharma Solutions Ltd.